Elevated levels of interleukin-6 (IL-6), vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and monocyte chemotactic protein-1 (MCP-1) have been implicated in the pathogenesis of myxomas. The gene discussed is CCL2; the disease is myxoma.